Corona Remedies - Allotment Status, Dates, Price Band & Details | MNCL Research

Corona Remedies Limited is an Indian pharmaceutical company focused on developing, manufacturing and marketing branded formulations across key therapeutic areas such as women’s health, diabetology, vitamins & nutrients, pain management, cardiology, urology and gastrointestinal care. The company has steadily expanded its presence in urban and semi-urban markets, supported by a strong field force and a pan-India distribution network. Corona ranks among the fastest-growing pharma players in the Indian Pharmaceutical Market (IPM), backed by successful new product launches, specialist doctor engagement and a diversified product basket
IPO Dates
- IPO Open Date: Mon, Dec 8, 2025
- IPO Close Date: Wed, Dec 10, 2025
- Tentative Listing Date : Mon, Dec 15, 2025
IPO Details
- Face Value: ₹10 per share
- Issue Price Band: ₹1008 to ₹1062 per share
- Lot Size: 14 Shares
- Sale Type: Offer for Sale
- Total Issue Size: 61,71,101 shares (aggregating up to ₹655.37 Cr)
- Employee Discount: ₹54 per share
- Issue Type: 100% Book Built Issue
- Listing At: NSE & BSE
Competitive Strengths
- Second fastest growing company in the top 30 Indian pharmaceutical companies by domestic sales from MAT June 2022 to MAT June 2025, well-positioned to seize opportunities in the Indian market.
- Demonstrated capabilities of building a diversified portfolio, including “engine” brands, in our targeted therapy areas.
- Pan-India sales network and marketing strategy focused on the “middle of the pyramid” target market.
- Quality and current Good Manufacturing Practices-focused manufacturing facilities, with strong research and development capabilities driving a portfolio of differentiated pharmaceutical products.
- Qualified, experienced and entrepreneurial management team supported by marquee investors.
Allotment Details:
- Bigshare Services Pvt. Ltd.: https://ipo.bigshareonline.com/IPO_Status.html
- NSE: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
- BSE: https://www.bseindia.com/investors/appli_check.aspx
Empower your IPO investment journey — stay informed with accurate dates, price band and filings.
Track Live & Upcoming IPOs
Corona Remedies Limited IPO – Frequently Asked Questions (FAQ)
1. What does Corona Remedies Limited do?
Corona Remedies Limited is an Indian pharmaceutical company engaged in developing, manufacturing and marketing branded formulations across therapeutic areas such as women’s health, diabetology, vitamins, pain management, cardiology, urology and gastrointestinal care.
2. When does the Corona Remedies IPO open and close?
The IPO opens on December 8, 2025, and closes on December 10, 2025.
3. What is the tentative listing date for the Corona Remedies IPO?
The tentative listing date is December 15, 2025.
4. What is the price band for the Corona Remedies IPO?
The price band is set between ₹1008 and ₹1062 per share.
5. What is the lot size for the Corona Remedies IPO?
The lot size is 14 shares.
6. What is the total issue size of the Corona Remedies IPO?
The total issue size is 61,71,101 shares, aggregating up to ₹655.37 crore.
7. Is the Corona Remedies IPO a Fresh Issue or Offer for Sale?
The IPO is an Offer for Sale (OFS) only.
8. Is there an employee discount in the IPO?
Yes, eligible employees receive a discount of ₹54 per share.
9. On which exchanges will the IPO be listed?
The IPO will be listed on NSE and BSE.
10. What are the competitive strengths of Corona Remedies?
Key strengths include strong growth in the Indian pharmaceutical market, diversified product portfolio, pan-India sales network, quality-focused manufacturing facilities, and an experienced management team supported by marquee investors.
11. Where can investors check the Corona Remedies IPO allotment status?
Allotment can be checked on Bigshare Services (Registrar), NSE, and BSE using the official links provided in the IPO details.
Investor Education Hub: Everything You Need to Know About IPOs
- How to Analyse an IPO Before Applying
- Step-by-Step Guide: IPO Process in India
- Understanding IPO Application & Allotment (UPI / ASBA & Eligibility)
- 8 Tips to Improve Your Chances of IPO Allotment
Disclaimer: - Investments in securities market are subject to market risk, read all the related document carefully before investing. https://www.mnclgroup.com/research-disclaimer

